Watsupptoday Desk


According to the Indian Council of Medical Research, three Indian vaccines are in different phases of clinical testing at present.Pharmaceutical companies in India and around the world are putting in great efforts to treat the coronavirus disease which has infected more than 20 million people so far.Many scientific studies are also being done as part of efforts to find treatments and vaccines for Covid-19, the illness caused by the Sars-CoV-2 virus.

A total of 26 vaccine candidates are being developed, according to the World Health Organisation as a process normally taking up to 15 years has been squeezed into a matter of months.

1. In India, an expert committee on vaccine administration will meet on Wednesday to consider �logistics and ethical aspects� of procurement and administration of vaccines against Covid-19, the Uniomn health ministry said today. The committee will be chaired by NITI Aayog�s Dr VK Paul. The coronavirus disease has infected more than 2.2 million people and killed over 44,000 in India.

2. According to the Indian Council of Medical Research (ICMR), three Indian vaccines are in different phases of clinical testing at present. Two of these vaccines - Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 clinical trials, said the ICMR.

3. Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites, the institute said.

Meanwhile, Moderna has become the first company in the world to begin phase 3 testing of its coronavirus vaccine. The tests are being carried out at its facilities in the United States. The tests started on July 27 and the company plans to enroll 30,000 study subjects.